Lv L - Search Results

1

Solid component proportion is an important predictor of tumor invasiveness in clinical stage T₁N₀M₀ (cT₁N₀M₀) lung adenocarcinoma.

Li M, Wu N, Zhang L, Sun W, Liu Y, Lv L, Ren J, Lin D. Li M, et al. Among authors: lv l. Cancer Imaging. 2018 May 4;18(1):18. doi: 10.1186/s40644-018-0147-7. Cancer Imaging. 2018. PMID: 29728140 Free PMC article.

2

Pathologic N₀ Status in Clinical T₁N₀M₀ Lung Adenocarcinoma is Predictable by the Solid Component Proportion with Quantitative CT Number Analysis.

Li M, Wu N, Zhang L, Sun W, Wang J, Lv L, Ren J, Lin D. Li M, et al. Among authors: lv l. Sci Rep. 2017 Dec 1;7(1):16810. doi: 10.1038/s41598-017-16701-x. Sci Rep. 2017. PMID: 29196627 Free PMC article.

3

Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non-small cell lung cancer.

Hou D, Zheng X, Song W, Liu X, Wang S, Zhou L, Tao X, Lv L, Sun Q, Jin Y, Zhang Z, Ding L, Wu N, Zhao S. Hou D, et al. Among authors: lv l. Thorac Cancer. 2021 Sep;12(17):2388-2399. doi: 10.1111/1759-7714.14083. Epub 2021 Jul 20. Thorac Cancer. 2021. PMID: 34288491 Free PMC article. Clinical Trial.

4

Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis.

Zhang L, Lv L, Li L, Wang YM, Zhao S, Miao L, Gao YN, Li M, Wu N. Zhang L, et al. Among authors: lv l. Diagnostics (Basel). 2022 Aug 6;12(8):1907. doi: 10.3390/diagnostics12081907. Diagnostics (Basel). 2022. PMID: 36010257 Free PMC article.

5

MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer.

Zhao S, Hou D, Zheng X, Song W, Liu X, Wang S, Zhou L, Tao X, Lv L, Sun Q, Jin Y, Ding L, Mao L, Wu N. Zhao S, et al. Among authors: lv l. Transl Lung Cancer Res. 2021 Jan;10(1):368-380. doi: 10.21037/tlcr-20-361. Transl Lung Cancer Res. 2021. PMID: 33569319 Free PMC article.

6

Radiomic-signature changes after early treatment improve the prediction of progression-free survival in patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Hou D, Zheng X, Song W, Liu X, Wang S, Zhou L, Tao X, Lv L, Sun Q, Jin Y, Zhang Z, Ding L, Wu N, Zhao S. Hou D, et al. Among authors: lv l. Acta Radiol. 2023 Mar;64(3):1194-1204. doi: 10.1177/02841851221119621. Epub 2022 Aug 15. Acta Radiol. 2023. PMID: 35971221

7

Spectra-based color correction method of liquid crystal displays.

Wu T, Lv L, Wang Z, Huang Z, Xie X. Wu T, et al. Among authors: lv l. Opt Express. 2024 Sep 9;32(19):32691-32702. doi: 10.1364/OE.534063. Opt Express. 2024. PMID: 39572990

8

Surgical Efficacy Analysis of Traumatic posterior fossa epidural Hematoma in Chidren.

Chen T, Xue P, Wang M, Ye H, Lv L. Chen T, et al. Among authors: lv l. World Neurosurg. 2024 Nov 19:S1878-8750(24)01897-7. doi: 10.1016/j.wneu.2024.11.037. Online ahead of print. World Neurosurg. 2024. PMID: 39571895

9

Author Correction: Interfacial microstructure and corrosion behavior of ODS FeCrAl alloy in oxygen-saturated lead-bismuth eutectic at 450 °C.

Luo Y, Ma S, Lv P, Liu Y, Wang X, Lv L, Xing J. Luo Y, et al. Among authors: lv l. Sci Rep. 2024 Nov 20;14(1):28728. doi: 10.1038/s41598-024-79831-z. Sci Rep. 2024. PMID: 39567609 Free PMC article. No abstract available.

10

Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway.

Deng Z, Ou M, Shi Y, Li G, Lv L. Deng Z, et al. Among authors: lv l. Toxicol Appl Pharmacol. 2024 Nov 17:117158. doi: 10.1016/j.taap.2024.117158. Online ahead of print. Toxicol Appl Pharmacol. 2024. PMID: 39561883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,945 results

Search Page

Filters